Wave Life Sciences (WVE) Current Assets (2014 - 2026)

Wave Life Sciences' Current Assets history runs 13 years deep, the most recent figure standing at $561.3 million for Q1 2026.

• Quarterly Current Assets rose 117.57% year-over-year to $561.3 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $561.3 million (up 117.57% YoY) and the FY2025 annual result came in at $614.8 million, up 91.89% from the prior year.
• Current Assets was $561.3 million for Q1 2026 at Wave Life Sciences, down from $614.8 million in the prior quarter.
• Across five years, Current Assets topped out at $614.8 million in Q4 2025 and bottomed at $98.5 million in Q4 2022.
• A 5-year average of $247.0 million and a median of $215.5 million in 2025 frame the typical range for Current Assets.
• Annual changes were most pronounced in 2022 — Current Assets plunged 39.39% — and 2023, when it surged 138.87%.
• Wave Life Sciences' Current Assets stood at $98.5 million in 2022, then jumped by 138.87% to $235.4 million in 2023, then jumped by 36.12% to $320.4 million in 2024, then surged by 91.89% to $614.8 million in 2025, then declined by 8.71% to $561.3 million in 2026.
• Business Quant data shows WVE's Current Assets at $561.3 million in Q1 2026, $614.8 million in Q4 2025, and $215.5 million in Q3 2025.